We confirmed that there was no compensatory effect of AMPKα2 expression in PRKAA1-knockdown spheroid cells that could explain this lack of effect, nor did PRKAA2 siRNA elicit any change in total AMPKα expression in ovarian cancer cell lines (data not shown). The gene discussed is PRKAA2; the disease is ovarian carcinoma.